Pfizer Inc mentioned on Wednesday booster doses of its COVID-19 vaccine may be administered together with its pneumonia vaccine and produced robust security and immune responses in folks aged 65 and above in a late-stage research.
The research, initiated in Could, examined the corporate’s next-generation pneumococcal conjugate vaccine, PREVNAR 20, with a 3rd dose of the Pfizer-BioNTech COVID-19 shot in 570 members.
The goal of the research was to check the security of the mixture and the immune response after including the pneumonia vaccine to the present COVID-19 vaccine.
The corporate mentioned responses elicited by PREVNAR 20 and a booster dose of the COVID-19 vaccine have been comparable when given collectively or with a placebo.
The information supplies proof supporting the potential to manage PREVNAR 20 and the corporate’s COVID-19 vaccine on the similar time, decreasing the variety of visits folks make to docs or pharmacies for advisable immunization, Pfizer mentioned.
PREVNAR 20 was authorised by the U.S. Meals and Drug Administration in June final yr to assist shield adults towards most invasive pneumococcal illnesses and pneumonia.
Examine members have been recruited from the businesses’ late-stage COVID-19 vaccine research and people who had obtained the second dose of the corporate’s COVID-19 vaccine a minimum of six months earlier than getting into the co-administration research.
The newest tech information delivered to your inbox
For extra information in regards to the novel coronavirus click on right here.
What you have to find out about Coronavirus.
For extra info on COVID-19, name the DOH Hotline: (02) 86517800 native 1149/1150.
The Inquirer Basis helps our healthcare frontliners and remains to be accepting money donations to be deposited at Banco de Oro (BDO) present account #007960018860 or donate via PayMaya utilizing this hyperlink .
Subscribe to INQUIRER PLUS to get entry to The Philippine Each day Inquirer & different 70+ titles, share as much as 5 devices, hearken to the information, obtain as early as 4am & share articles on social media. Name 896 6000.
For suggestions, complaints, or inquiries, contact us.